Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
21Ventures was a venture capital firm that specialized in seed and early-stage investments across several high-growth sectors, including life sciences, clean technology, and renewable energy. Founded by David Gladstone, the firm focused on identifying innovative technologies and providing the necessary capital and strategic guidance to accelerate market entry. In the healthcare space, 21Ventures invested in a variety of medical device and biotechnology companies, aiming to support breakthroughs in diagnostics and therapeutic delivery. While the firm was highly active during the mid-2000s, its operations have since wound down as its leadership transitioned to other investment vehicles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 21Ventures.